The results indicate that FOXO4-DRI potently and selectively reduces the viability of senescent fibroblasts compared to non-senescent controls (2.7-fold and 1.7-fold difference for keloid and normal skin, respectively)
Grant Engine helps defense and dual-use companies navigate this ecosystem, identifying the right mechanism, the right component, and the right moment to pursue, and building the proposals that win
staggered titration Cycle driver GI tolerance sets the pace Tirzepatide Loading 2.5 5 7.5 10 12.5 mg (every 4 weeks) Frequency Once weekly Maintenance 15 mg weekly Route SubQ Cagrilintide Loading Start Week 9: 0.25 0.5 1.0 1.7 mg Frequency Once weekly Maintenance 2.4 mg weekly Route SubQ Weekly Schedule Example (Maintenance Phase) Monday Tirzepatide 15 mg (one site) + Cagrilintide 2.4 mg (different site) Tuesday No injections Wednesday No injections Thursday No injections Friday No injections Saturday No injections Sunday No injections Both compounds are once weekly
GHK-Cu applied to thigh skin for 12 weeks improved collagen production in 70% of women treated compared to 50% treated with vitamin C cream and 40% with retinoic acid
The peptide may look fine but lose biological activity entirely
Neurological symptoms often develop gradually and may include: Paraesthesia : tingling or 'pins and needles' sensations, typically starting in the feet and hands Numbness : reduced sensation in the extremities, which may affect balance and coordination Burning pain : particularly in the feet, often worse at night Weakness : muscle weakness and difficulty walking Balance problems : unsteady gait and increased fall risk due to proprioceptive impairment Cognitive changes : memory problems, confusion, difficulty concentrating, and mood disturbances Haematological signs may accompany neurological symptoms and include fatigue, weakness, pallor, and shortness of breath due to megaloblastic anaemia